Sight Sciences, Inc.
SGHT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -1.5% | 13.6% | 45.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 85.5% | 85.3% | 82.7% | 82.4% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -57.5% | -61% | -112.8% | -116.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -64.5% | -68.5% | -120.9% | -128.6% |
| EPS Diluted | -1.03 | -1.14 | -1.8 | -1.33 |
| % Growth | 9.6% | 36.7% | -35.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |